Keen Eye Technologies
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Keen Eye Technologies - overview
Established
2013
Location
Paris, -, France
Primary Industry
Software
About
Founded in 2013 and based in Paris, France, Keen Eye Technologies SAS develops an image analysis platform that uses artificial intelligence for drug development and precision medicine. The platform determines predictive factors for disease events such as early detection and relapse.
Current Investors
Seventure Partners, Credit Mutuel Equity
Primary Industry
Software
Sub Industries
Healthcare IT, Analytics & Performance Software, Application Integration Software, Medical Software
Website
www.keeneye.tech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Keen Eye Technologies - financials
| Fiscal Year Ended | Dec 31, 2018 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |
Keen Eye Technologies - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.